• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

齐心协力抗击镰状细胞病:在加纳阿克拉举行的第一届全球镰状细胞病大会。

Concerted global effort to combat sickle cell disease: the first global congress on sickle cell disease in Accra, Ghana.

机构信息

Global Sickle Cell Disease Network, Programme for Global Paediatric Research, The Hospital for Sick Children, Toronto, Canada.

出版信息

Am J Prev Med. 2011 Dec;41(6 Suppl 4):S417-21. doi: 10.1016/j.amepre.2011.09.019.

DOI:10.1016/j.amepre.2011.09.019
PMID:22099367
Abstract

The First Global Congress on Sickle Cell Disease was held in Accra, Ghana, on July 20-23, 2010, to commemorate 100 years since the first published report of sickle cell disease (SCD). The idea of the Global Congress was conceived following the 2007 meeting in Nicosia, Cyprus, jointly organized by the WHO and the Thalassaemia International Federation (TIF), which recommended that groups working in SCD around the world needed to consolidate efforts into a stronger and more unified umbrella organization. The need for a united global effort received further endorsements at the 2009 International Symposium and Workshop held in Cotonou, Benin, and the 2009 inaugural commemoration of World Sickle Cell Disease Awareness Day, UN Headquarters, New York, New York. The overall goals of the Global Congress were to promote international cooperation and foster collaboration in advancing clinical care and furthering basic and applied research in SCD. Issues covered at the conference included health education, psychosocial needs, public health, medical care, research, program development, and development of international community-based organizations. The Congress participants included medical and research scientists, public health officials, community-based SCD organizations, other nongovernmental organizations, and people with SCD and their families. The Congress concluded with a call on patients and families affected by SCD, as well as advocacy groups, healthcare professionals, scientists, and national governments working to combat SCD to endorse the formation of the World Sickle Cell Disease Federation.

摘要

第一届镰状细胞病全球大会于 2010 年 7 月 20 日至 23 日在加纳的阿克拉举行,旨在纪念第一份镰状细胞病(SCD)报告发表 100 周年。全球大会的构想源于 2007 年在塞浦路斯尼科西亚举行的会议,该会议由世界卫生组织(WHO)和国际地中海贫血症联合会(TIF)联合组织,会议建议全世界从事 SCD 工作的组织需要将努力整合到一个更强大、更统一的伞式组织中。在贝宁科托努举行的 2009 年国际研讨会和讲习班以及 2009 年在纽约联合国总部举行的世界镰状细胞病意识日首次纪念活动上,对全球统一努力的需求得到了进一步认可。全球大会的总体目标是促进国际合作,促进临床护理的协作,并推进 SCD 的基础和应用研究。会议涵盖的问题包括健康教育、社会心理需求、公共卫生、医疗保健、研究、项目开发以及国际社区组织的发展。大会参与者包括医学和研究科学家、公共卫生官员、以社区为基础的 SCD 组织、其他非政府组织以及 SCD 患者及其家人。大会最后呼吁受 SCD 影响的患者及其家属以及倡导团体、医疗保健专业人员、科学家和国家政府共同努力抗击 SCD,支持成立世界镰状细胞病联合会。

相似文献

1
Concerted global effort to combat sickle cell disease: the first global congress on sickle cell disease in Accra, Ghana.齐心协力抗击镰状细胞病:在加纳阿克拉举行的第一届全球镰状细胞病大会。
Am J Prev Med. 2011 Dec;41(6 Suppl 4):S417-21. doi: 10.1016/j.amepre.2011.09.019.
2
Developing a global agenda for sickle cell disease: report of an international symposium and workshop in Cotonou, Republic of Benin.制定全球镰状细胞病议程:贝宁共和国科托努国际研讨会和讲习班报告。
Am J Prev Med. 2010 Apr;38(4 Suppl):S571-5. doi: 10.1016/j.amepre.2009.12.021.
3
Bridging the Access Gap for Comprehensive Sickle Cell Disease Management Across Sub-Saharan Africa: Learnings for Other Global Health Interventions?弥合撒哈拉以南非洲地区全面镰状细胞病管理中的获取障碍:对其他全球卫生干预措施的启示?
Ann Glob Health. 2023 Nov 14;89(1):76. doi: 10.5334/aogh.4132. eCollection 2023.
4
Access to essential therapy for sickle cell disease in Africa: Experience from a national program in Ghana.在非洲获得治疗镰状细胞病的基本疗法:加纳国家方案的经验。
Semin Hematol. 2023 Sep;60(4):226-232. doi: 10.1053/j.seminhematol.2023.06.001. Epub 2023 Jul 7.
5
The Crisis of Sickle Cell Disease in Africa from Insights into Primary Prevention in Ghana and Nigeria: Notes from the Field.非洲镰状细胞病危机:从加纳和尼日利亚初级预防的新视角看问题:实地考察札记。
J Immigr Minor Health. 2021 Aug;23(4):871-878. doi: 10.1007/s10903-021-01186-8. Epub 2021 Mar 20.
6
Knowledge and nutrition-related practices among caregivers of adolescents with sickle cell disease in the Greater Accra region of Ghana.加纳大阿克拉地区镰状细胞病青少年照顾者的知识和营养相关实践。
BMC Public Health. 2023 Mar 6;23(1):434. doi: 10.1186/s12889-023-15343-1.
7
An Analysis of Racial and Ethnic Backgrounds Within the CASiRe International Cohort of Sickle Cell Disease Patients: Implications for Disease Phenotype and Clinical Research.分析国际镰状细胞病患者合作研究队列的种族和民族背景:对疾病表型和临床研究的影响。
J Racial Ethn Health Disparities. 2021 Feb;8(1):99-106. doi: 10.1007/s40615-020-00762-2. Epub 2020 May 16.
8
Sickle cell disease: embedding patient participation into an international conference can transform the role of lived experience.镰状细胞病:将患者参与融入国际会议可以改变患者经验的作用。
Orphanet J Rare Dis. 2023 Nov 1;18(1):341. doi: 10.1186/s13023-023-02951-8.
9
A qualitative study on stigma experienced by young adults living with sickle cell disease in Accra, Ghana.加纳阿克拉的一项关于患有镰状细胞病的年轻人所经历的耻辱感的定性研究。
Int Health. 2023 Nov 3;15(6):684-691. doi: 10.1093/inthealth/ihac087.
10
Community engagement to inform the development of a sickle cell counselor training and certification program in Ghana.社区参与以推动加纳镰状细胞病咨询师培训与认证项目的发展。
J Community Genet. 2016 Jul;7(3):195-202. doi: 10.1007/s12687-016-0267-3. Epub 2016 Apr 18.

引用本文的文献

1
Hydroxyurea therapy for neurological and cognitive protection in pediatric sickle cell anemia in Uganda (BRAIN SAFE II): Protocol for a single-arm open label trial.乌干达儿童镰状细胞贫血神经和认知保护的羟基脲治疗(BRAIN SAFE II):单臂开放标签试验方案
Contemp Clin Trials Commun. 2024 Nov 28;42:101404. doi: 10.1016/j.conctc.2024.101404. eCollection 2024 Dec.
2
Hydroxyurea Therapy for Neurological and Cognitive Protection in Pediatric Sickle Cell Anemia in Uganda (BRAIN SAFE II): Protocol for a single-arm open label trial.乌干达儿童镰状细胞贫血神经和认知保护的羟基脲疗法(BRAIN SAFE II):单臂开放标签试验方案
medRxiv. 2024 Jan 13:2024.01.12.24301208. doi: 10.1101/2024.01.12.24301208.
3
Empowering newborn screening programs in African countries through establishment of an international collaborative effort.
通过建立国际合作努力来加强非洲国家的新生儿筛查项目。
J Community Genet. 2020 Jul;11(3):253-268. doi: 10.1007/s12687-020-00463-7. Epub 2020 May 15.
4
Stroke Prevalence in Children With Sickle Cell Disease in Sub-Saharan Africa: A Systematic Review and Meta-Analysis.撒哈拉以南非洲地区镰状细胞病患儿的中风患病率:系统评价与荟萃分析
Glob Pediatr Health. 2018 May 14;5:2333794X18774970. doi: 10.1177/2333794X18774970. eCollection 2018.
5
Hydroxyurea Therapy for Children With Sickle Cell Anemia in Sub-Saharan Africa: Rationale and Design of the REACH Trial.撒哈拉以南非洲地区镰状细胞贫血患儿的羟基脲治疗:REACH试验的原理与设计
Pediatr Blood Cancer. 2016 Jan;63(1):98-104. doi: 10.1002/pbc.25705. Epub 2015 Aug 14.
6
[Psychosocial impact of sickle cell disease in the parents of children living in Kinshasa, Democratic Republic of Congo: a qualitative study].[刚果民主共和国金沙萨儿童镰状细胞病对其父母的心理社会影响:一项定性研究]
Pan Afr Med J. 2014 Sep 2;19:5. doi: 10.11604/pamj.2014.19.5.2830. eCollection 2014.
7
Improving outcomes in children with sickle cell disease: treatment considerations and strategies.改善镰状细胞病患儿的预后:治疗注意事项和策略。
Paediatr Drugs. 2014 Aug;16(4):255-66. doi: 10.1007/s40272-014-0074-4.
8
Global migration and the changing distribution of sickle haemoglobin: a quantitative study of temporal trends between 1960 and 2000.全球人口迁移与镰状血红蛋白分布变化:1960 年至 2000 年时间趋势的定量研究。
Lancet Glob Health. 2014 Feb;2(2):e80-9. doi: 10.1016/S2214-109X(13)70150-5.